Health ❯ Pharmaceuticals

Weight Management

Obesity Treatment GLP-1 Drugs GLP-1 Agonists Obesity Medications GLP-1 Medications Wegovy Obesity Treatments Diabetes Treatment Injectable Drugs Access to Medication Ozempic Substances Injectable Treatments Drug Safety GLP-1 Treatments Drug Approval GLP-1 Zepbound GLP-1 Receptor Agonists Weight Loss Injectable Medications Appetite Control Tirzepatide Clinical Research

Ex-North Texas Principal Charged Over Alleged Sale of GLP-1 Weight‑Loss Drugs

The case highlights gaps in school hiring checks that could prompt tighter vetting of educators.

UAE Becomes First Country Outside U.S. to Offer Wegovy Pill

Kris Jenner Says She Tried Ozempic Once and Quit After Getting ‘Really Sick’

Novo Nordisk Lifts Outlook After Wegovy Pill Fuels Q1 Beat

Eli Lilly Tightens GLP-1 Grip, Guides Up to $83 Billion for 2026

Eli Lilly’s GLP-1 Lead Faces New Pressure From Novo’s Weight-Loss Pill

FDA Clears Wegovy Pill, Handing Novo Nordisk a Short-Term Edge in Obesity-Drug Race

Novo Nordisk Slashes Wegovy Price in India by Up to 37% to Take On Mounjaro